STOCK TITAN
  1. Home
  2. News
  3. ZOM

Zomedica CEO Issues Shareholder Letter as TRUFORMA™ Nears Commercialization

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

ANN ARBOR, Mich., Jan. 18, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today issued the following letter from Robert Cohen, Chief Executive Officer, updating Zomedica’s shareholders regarding several key activities and events:

Dear Shareholders:

I am hopeful that you had a pleasant holiday season and wish you the best during the new year. We at Zomedica are excited as we enter

Stock ZOM logo
Zomedica Corp

NYSE:ZOM

ZOM Rankings

#4070 Ranked by Market Cap
#3990 Ranked by Stock Gains
N/A Ranked by Dividends

ZOM Latest News

Apr 19, 2024
Senstar Technologies Corporation Reports Fourth Quarter and Full Year 2023 Financial Results
Apr 9, 2024
Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024
Apr 1, 2024
Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity
Mar 20, 2024
Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ET
Mar 14, 2024
Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform

ZOM Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Health Technology, Pharmaceuticals: Major, Miscellaneous, Manufacturing, Pharmaceutical Preparation Manufacturing

About ZOM

zomedica (nyse american:zom) (tsx-v:zom) is a veterinary diagnostic and pharmaceutical and company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. zomedica’s product portfolio will include novel diagnostics and innovative therapeutics that emphasize patient health and practice health. with a team that includes clinical veterinary professionals, it is zomedica’s mission to give veterinarians the opportunity to lower costs, increase productivity, and grow revenue while better serving the animals in their care.